As communicated on January 21, 2020, CTS will implement the licensed Grifols Babesia test for samples received on April 20, at the Charlotte, Dallas, Phoenix, St. Louis and Tampa laboratories. Babesia is a selective pooled NAT test, required for all blood donations collected by May 2020, in 14 States and the District of Columbia. To help you understand the requirements, CTS will host a Babesia Implementation and Review webinar on March 3, 2020 at 11:00 am CST. If you are interested in attending, please contact your Customer Service Manager for invitation details.
CTS lab staff recently participated in a Kaizen and determined emailed Daily Shipment Schedules to b...
CTS will be transitioning to a new sFTP server for clients who send test request and/or receive...
On April 15, 2019, the New CTS Laboratory Information System has been successfully implemented in Po...
On January 25, 2021, CTS implements the Ortho VIP viral marker testing platform. Conversion from the...
CTS Charlotte Lab successfully implemented WNV NAT testing on the Panther Testing Platform on Monday...
This is the first update to the original CTS communication distributed on July 6th. As previously co...